Karuna Therapeutics (KRTX) Short Interest Ratio & Short Volume → Bill Clinton Backing Biden Replacement??? (From The Freeport Society) (Ad) Free KRTX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrendsStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrends Karuna Therapeutics Short Interest DataCurrent Short Interest1,970,000 sharesPrevious Short Interest2,110,000 sharesChange Vs. Previous Month-6.64%Dollar Volume Sold Short$618.52 millionShort Interest Ratio2.3 Days to CoverLast Record DateFebruary 29, 2024Outstanding Shares38,148,000 sharesPercentage of Shares Shorted5.16%Today's Trading Volume5 sharesAverage Trading Volume832,048 sharesToday's Volume Vs. Average0% Short Selling Karuna Therapeutics ? Sign up to receive the latest short interest report for Karuna Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartKRTX Short Interest Over TimeKRTX Days to Cover Over TimeKRTX Percentage of Float Shorted Over Time Ad The Freeport SocietyBill Clinton Backing Biden Replacement???Bill Clinton is back. And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August…Click here now for my urgent election forecast. Karuna Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/29/20241,970,000 shares $618.52 million -6.6%N/A2.3 $313.97 2/15/20242,110,000 shares $673.91 million +24.9%N/A2.5 $319.39 1/31/20241,690,000 shares $529.68 million +15.8%N/A2.1 $313.42 1/15/20241,460,000 shares $462.46 million -4.6%N/A2 $316.75 12/31/20231,530,000 shares $484.26 million -24.3%N/A2.5 $316.51 12/15/20232,020,000 shares $443.94 million -1.5%N/A4.7 $219.77 Get the Latest News and Ratings for KRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Karuna Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/30/20232,050,000 shares $391.98 million +7.3%N/A7.7 $191.21 11/15/20231,910,000 shares $328.06 million +3.8%N/A8.1 $171.76 10/31/20231,840,000 shares $306.56 million +12.2%N/A7.7 $166.61 10/15/20231,640,000 shares $280.46 million -1.8%N/A6.5 $171.01 9/30/20231,670,000 shares $282.38 million +18.4%N/A6.6 $169.09 9/15/20231,410,000 shares $255.07 million +4.4%N/A5.3 $180.90 8/31/20231,350,000 shares $253.48 million -6.9%N/A3.9 $187.76 8/15/20231,450,000 shares $260.26 million +16.0%N/A4 $179.49 7/31/20231,250,000 shares $249.71 million -1.6%N/A3.3 $199.77 7/15/20231,270,000 shares $269.01 million -4.5%N/A3.3 $211.82 6/30/20231,330,000 shares $288.41 million -37.0%N/A3.3 $216.85 6/15/20232,110,000 shares $503.34 million -0.9%N/A5 $238.55 5/31/20232,130,000 shares $482.55 million +2.4%N/A5.2 $226.55 5/15/20232,080,000 shares $479.69 million -2.4%N/A5 $230.62 4/30/20232,130,000 shares $422.68 million +1.4%N/A5.1 $198.44 4/15/20232,100,000 shares $383.54 million -1.9%N/A5.2 $182.64 3/31/20232,140,000 shares $388.71 million +22.3%N/A5.5 $181.64 3/15/20231,750,000 shares $327.37 million +0.6%N/A4.8 $187.07 2/28/20231,740,000 shares $346.99 million +4.2%6.1%5.8 $199.42 2/15/20231,670,000 shares $324.23 million No Change5.9%5.8 $194.15 1/31/20231,670,000 shares $332.98 million -0.6%6.0%5.8 $199.39 1/15/20231,680,000 shares $337.26 million -2.9%6.0%5.7 $200.75 12/30/20221,730,000 shares $339.95 million +10.9%6.3%5.8 $196.50 12/15/20221,560,000 shares $312 million +6.1%5.6%4.8 $200.00 11/30/20221,470,000 shares $345.91 million -13.5%5.4%4.1 $235.31 11/15/20221,700,000 shares $392.31 million +4.9%6.2%4.8 $230.77 10/31/20221,620,000 shares $355.33 million No Change6.2%3.6 $219.34 10/15/20221,620,000 shares $333.56 million +14.9%6.4%3 $205.90 9/30/20221,410,000 shares $317.15 million -23.4%5.6%2.7 $224.93 9/15/20221,840,000 shares $449.07 million -1.1%7.3%3.5 $244.06 8/31/20221,860,000 shares $474.41 million -9.7%7.6%3.6 $255.06 8/15/20222,060,000 shares $563.84 million +36.4%8.4%4.2 $273.71 7/31/20221,510,000 shares $196.68 million +6.3%7.0%3.8 $130.25 7/15/20221,420,000 shares $191.97 million +5.2%6.6%4.7 $135.19Bill Clinton Backing Biden Replacement??? (Ad)Bill Clinton is back. And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August…Click here now for my urgent election forecast. 6/30/20221,350,000 shares $170.79 million +13.5%6.2%4.5 $126.51 6/15/20221,190,000 shares $122.52 million +19.0%5.5%4.4 $102.96 5/31/20221,000,000 shares $104.32 million +1.6%4.6%4.3 $104.32 5/15/2022984,700 shares $102.31 million -3.5%4.5%4.3 $103.90 4/30/20221,020,000 shares $113.69 million -1.0%4.7%4.6 $111.46 4/15/20221,030,000 shares $141.83 million +6.6%4.8%5.1 $137.70 3/31/2022966,000 shares $122.48 million +7.8%4.5%4.6 $126.79 3/15/2022896,400 shares $93.99 million +8.1%N/A4.5 $104.85 2/28/2022829,200 shares $87.07 million -14.3%3.8%4.1 $105.00 2/15/2022967,700 shares $108.39 million -2.6%4.5%4.7 $112.01 1/31/2022993,500 shares $110.34 million -16.5%4.6%5.3 $111.06 1/15/20221,190,000 shares $148.12 million +0.9%5.5%6.6 $124.47 12/31/20211,180,000 shares $154.58 million -11.9%5.5%7.2 $131.00 12/15/20211,340,000 shares $156.93 million -2.9%6.2%8.6 $117.11 11/30/20211,380,000 shares $176.50 million -6.1%6.4%9.7 $127.90 11/15/20211,470,000 shares $198.76 million -13.0%6.9%11.1 $135.21 10/29/20211,690,000 shares $237.24 million +1.2%8.2%14.4 $140.38 10/15/20211,670,000 shares $206.70 million No Change8.0%13.9 $123.77 9/30/20211,670,000 shares $204.29 million No Change8.0%12.4 $122.33 9/15/20211,670,000 shares $191.60 million -11.2%7.9%10.2 $114.73 8/31/20211,880,000 shares $223.53 million No Change8.9%10.8 $118.90 8/13/20211,880,000 shares $200.84 million -6.9%8.9%10.6 $106.83 7/30/20212,020,000 shares $230.72 million +4.1%9.6%11.4 $114.22 7/15/20211,940,000 shares $218.89 million +1.0%9.2%11.5 $112.83 6/30/20211,920,000 shares $218.86 million +1.6%9.1%11.5 $113.99 6/15/20211,890,000 shares $239.84 million -3.1%9.0%12.9 $126.90 5/28/20211,950,000 shares $218.05 million +6.6%9.3%12.8 $111.82 5/14/20211,830,000 shares $211.79 million +10.2%8.7%9.9 $115.73 4/30/20211,660,000 shares $183.45 million -1.8%8.0%8.2 $110.51 4/15/20211,690,000 shares $195.09 million -3.4%8.2%7.8 $115.44 3/31/20211,750,000 shares $204.54 million +5.4%8.9%8.3 $116.88 3/15/20211,660,000 shares $198.27 million +8.5%8.4%7.7 $119.44 2/26/20211,530,000 shares $184.84 million +4.8%7.8%7.8 $120.81 2/12/20211,460,000 shares $172.00 million +14.1%8.1%9 $117.81 1/29/20211,280,000 shares $126.18 million +2.4%7.1%7.8 $98.58 1/15/20211,250,000 shares $126.06 million -12.6%7.0%8.3 $100.85 12/31/20201,430,000 shares $148.18 million -4.0%8.1%9.8 $103.62 12/15/20201,490,000 shares $140.78 million -8.0%8.4%9.6 $94.48 11/30/20201,620,000 shares $162 million -8.0%9.1%9.7 $100.00 11/15/20201,760,000 shares $169.24 million +8.0%10.0%9.4 $96.16 10/30/20201,630,000 shares $131.56 million +2.5%9.3%9.1 $80.71 10/15/20201,590,000 shares $127.92 million +2.6%9.1%9.5 $80.45 9/30/20201,550,000 shares $119.85 million +14.0%8.9%9 $77.32 9/15/20201,360,000 shares $113.89 million -7.5%7.8%7.2 $83.74 8/31/20201,470,000 shares $112.31 million -11.5%8.4%7.2 $76.40 8/14/20201,660,000 shares $143.26 million -1.2%10.3%8 $86.30 7/31/20201,680,000 shares $137.42 million -7.7%10.7%7.4 $81.80 7/15/20201,820,000 shares $170.39 million -3.7%11.8%7.5 $93.62 6/30/20201,890,000 shares $200.83 million +67.3%12.3%7.5 $106.26 6/15/20201,130,000 shares $107.90 million +10.8%7.3%4.5 $95.49Bill Clinton Backing Biden Replacement??? (Ad)Bill Clinton is back. And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August…Click here now for my urgent election forecast. 5/29/20201,020,000 shares $91.92 million No Change6.6%4 $90.12 5/15/20201,020,000 shares $82.62 million +17.3%6.9%3.8 $81.00 4/30/2020869,400 shares $74.05 million -13.9%5.8%3.4 $85.17 4/15/20201,010,000 shares $72.10 million +4.3%6.7%3.1 $71.39 3/31/2020968,400 shares $83.91 million +14.4%7.1%2.4 $86.65 3/13/2020846,700 shares $57.83 million +14.0%6.2%3.7 $68.30 2/28/2020742,600 shares $53.36 million +0.1%5.4%1.5 $71.86 2/14/2020742,100 shares $63.72 million -10.5%5.4%1.3 $85.86 1/31/2020829,400 shares $71.08 million +28.1%6.1%0.9 $85.70 1/15/2020647,500 shares $63.42 million -17.0%4.8%0.8 $97.94 12/31/2019780,300 shares $77.83 million +111.4%6.8%1.1 $99.75 KRTX Short Interest - Frequently Asked Questions What is Karuna Therapeutics' current short interest? Short interest is the volume of Karuna Therapeutics shares that have been sold short but have not yet been covered or closed out. As of February 29th, investors have sold 1,970,000 shares of KRTX short. Learn More on Karuna Therapeutics' current short interest. What is a good short interest ratio for Karuna Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KRTX shares currently have a short interest ratio of 2.0. Learn More on Karuna Therapeutics's short interest ratio. Which institutional investors are shorting Karuna Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Karuna Therapeutics: Walleye Trading LLC, and PEAK6 Investments LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Karuna Therapeutics' short interest increasing or decreasing? Karuna Therapeutics saw a decline in short interest during the month of February. As of February 29th, there was short interest totaling 1,970,000 shares, a decline of 6.6% from the previous total of 2,110,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Karuna Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Karuna Therapeutics: Taro Pharmaceutical Industries Ltd. (0.91%), OPKO Health, Inc. (26.01%), ADC Therapeutics SA (1.36%), Takeda Pharmaceutical Company Limited (0.21%), Alnylam Pharmaceuticals, Inc. (2.01%), Teva Pharmaceutical Industries Limited (1.16%), Genmab A/S (0.45%), Royalty Pharma plc (3.47%), BeiGene, Ltd. (1.75%), BioMarin Pharmaceutical Inc. (1.97%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.39 billion), General Motors ($3.88 billion), Super Micro Computer, Inc. ($3.51 billion), Charter Communications, Inc. ($3.22 billion), Occidental Petroleum Co. ($3.13 billion), Tractor Supply ($2.76 billion), Coinbase Global, Inc. ($2.63 billion), Suncor Energy Inc. ($2.48 billion), Moderna, Inc. ($2.04 billion), and Royal Caribbean Cruises Ltd. ($1.87 billion). View all of the most shorted stocks. What does it mean to sell short Karuna Therapeutics stock? Short selling KRTX is an investing strategy that aims to generate trading profit from Karuna Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Karuna Therapeutics? A short squeeze for Karuna Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KRTX, which in turn drives the price of the stock up even further. How often is Karuna Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KRTX, twice per month. The most recent reporting period available is February, 29 2024. More Short Interest Resources from MarketBeat Related Companies: Taro Pharmaceutical Industries Short Interest OPKO Health Short Interest ADC Therapeutics Short Interest Takeda Pharmaceutical Short Interest Alnylam Pharmaceuticals Short Interest Teva Pharmaceutical Industries Short Interest Genmab A/S Short Interest Royalty Pharma Short Interest BeiGene Short Interest BioMarin Pharmaceutical Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KRTX) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsWrite this ticker symbol down…StocksToTradeTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBill Gates is all about this tiny $2 stockTimothy SykesBill Clinton Backing Biden Replacement???The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Karuna Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.